Equity Securities (Details Narrative) - USD ($)
|
|
|
|
|
1 Months Ended |
3 Months Ended |
12 Months Ended |
|
|
|
|
|
|
|
|
|
|
|
|
|
Jul. 12, 2021 |
Jun. 29, 2021 |
Mar. 15, 2021 |
Jun. 14, 2019 |
Apr. 25, 2022 |
Aug. 31, 2021 |
Aug. 17, 2021 |
Mar. 31, 2021 |
Jun. 30, 2020 |
May 31, 2020 |
Nov. 30, 2016 |
Mar. 31, 2021 |
Dec. 31, 2022 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Dec. 31, 2018 |
Dec. 31, 2016 |
Jul. 11, 2022 |
Jun. 30, 2022 |
Jul. 31, 2021 |
Jul. 30, 2021 |
Jul. 01, 2021 |
Jun. 30, 2021 |
Mar. 24, 2021 |
Mar. 23, 2021 |
Mar. 31, 2020 |
Jun. 30, 2019 |
Mar. 31, 2017 |
Feb. 28, 2017 |
Dec. 31, 2015 |
Common stock, shares available for issuances |
|
593,340
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,648,213
|
|
|
|
|
|
|
|
|
Pre-funded warrants to purchase common share |
|
|
|
|
2,875,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
6,906,244
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net consideration |
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,833,877
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Increasing shares authorized for issuance |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
12,321,848
|
8,328,629
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stocks, authorized |
|
|
|
|
|
|
|
|
|
|
|
|
90,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, expire date |
|
|
|
|
|
|
|
|
|
|
|
|
August 17, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, Conversion of Stock, Shares Converted |
|
|
|
|
|
|
65,823,015
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares issued |
|
|
|
|
|
|
|
|
|
|
|
|
12,321,848
|
8,328,629
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description of difference |
The Company compared the fair value of the Series 1d Preferred Stock, as amended, to its carrying value and recorded the resulting difference of approximately $2.3 million as a deemed dividend for the Series 1d preferred shareholders
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,221,156
|
|
5,221,156
|
|
|
|
5,221,156
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
|
$ 930,325
|
$ 1,905,408
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Conversion, Converted Instrument, Principal Amount |
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,300,000
|
|
$ 1,145,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Board of Directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentages of initial public per share offering price |
|
|
|
|
|
|
|
|
|
|
|
|
8.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description of reverse split |
|
1-for-20.5 reverse split
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 20.50
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
69,212
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
69,212
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, issued |
|
|
|
|
|
69,212
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underwriter IPO Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, expire date |
|
|
|
|
|
|
|
|
|
|
|
|
August 17, 2026
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
128,571
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase share of common stock |
|
|
|
|
|
128,571
|
|
|
|
|
|
|
128,571
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase share of common stock, Exercise price Percentage of public offering price |
|
|
|
|
|
115.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase share of common stock, Exercise price |
|
|
|
|
|
$ 8.05
|
|
|
|
|
|
|
$ 8.05
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
License Agreement | Villani, Inc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Units, surrendered |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,221,156
|
|
|
|
|
|
|
|
|
|
Carrying value |
|
|
|
|
|
|
$ 730,962
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deemed dividend |
|
|
|
|
|
|
$ 269,038
|
|
|
|
|
|
$ 269,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IPO | Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant units to purchase stocks |
|
|
|
|
|
|
2,957,142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares sold |
|
|
|
|
|
|
2,571,428
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase one share of common stock |
|
|
|
|
|
|
2,571,428
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
2,957,142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
2,957,142
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
$ 7
|
|
|
|
|
|
$ 7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional shares of warrant |
|
|
|
|
|
|
385,714
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Closing trading price |
|
|
|
|
|
|
$ 0.9995
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
License Agreements | Villani, Inc |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,221,156
|
|
|
Common Stock and Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,911,009
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
$ 0.0001
|
|
|
$ 5.7
|
|
|
|
$ 5.7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.52
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PIPE Common Stock, Conversion of Stock, Shares Issued |
|
|
|
|
|
|
|
|
|
|
|
|
3,773,585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Conversion of Stock, Shares Issued |
|
|
|
|
|
3,813,973
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underwriters' discounts and offering expenses |
|
|
|
|
$ 70,000
|
|
$ 2,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred and common stock par value per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
Common stock, shares sold |
|
|
|
|
898,585
|
2,571,428
|
2,571,428
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre funded |
|
|
|
|
2,875,000
|
|
|
|
|
|
|
|
2,000,000
|
|
|
|
|
|
|
875,000
|
|
|
|
|
|
|
|
|
|
|
|
Pre funded outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase one share of common stock |
|
|
|
|
|
2,957,142
|
2,571,428
|
|
|
|
|
|
3,773,585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase one share of common stock, Exercise price |
|
|
|
|
$ 1.325
|
|
$ 7
|
|
|
|
|
|
$ 1.325
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Offering price |
|
|
|
|
|
|
7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options exercised to purchase additional warrants, Exercise price |
|
|
|
|
|
|
$ 7
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance initial public offering |
|
|
|
|
$ 4,300,000
|
|
$ 1,540,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series 1d Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
686,742
|
|
|
|
686,742
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion price per share |
|
|
|
|
|
|
|
$ 0.83
|
|
|
|
$ 0.83
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of preferred units |
|
|
|
|
|
|
|
$ 570,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subordinated convertible promissory notes interest |
|
|
$ 73,801
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subordinated convertible promissory notes |
|
|
$ 4,391,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subordinated convertible promissory notes converted into shares units |
|
|
5,379,247
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series 1a Preferred Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,018,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock, Conversion of Stock, Shares Converted |
|
|
|
|
|
1,419,228
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
20.50
|
|
|
|
|
|
|
|
|
|
|
|
$ 20.50
|
|
|
|
|
|
|
Warrant units to purchase stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,250,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consideration of warrants exercised |
|
|
|
|
|
|
|
|
$ 18,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Conversion of Stock, Warrant Exercisable |
|
|
|
|
|
69,212
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series 1a Preferred Units | Loan and Security Agreement with Silicon Valley Bank |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
|
Warrant units to purchase stocks |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
187,978
|
|
Series 1a Preferred Units | Loan and Security Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 1
|
|
|
|
|
|
Series 1c Preferred Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
46,553,188
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,221,156
|
|
|
|
Net of issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 25,857
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financing from current and new investors |
|
|
|
$ 5,785,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash proceeds |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,535,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash received from conversion of convertible note issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 150,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accrued interest on the convertible note |
|
|
|
1,487
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Remaining balance committed to financing payable amount |
|
|
|
$ 250,000
|
|
|
|
|
125,000
|
$ 125,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class B Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,767,477
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common units issued |
|
|
|
|
|
|
|
22,494
|
|
|
|
22,494
|
|
|
133,953
|
|
|
|
|
|
|
|
|
|
|
|
2,439
|
|
|
|
|
Common units issued consideration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,853
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common units issued as profits interest |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
365,245
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thresholds price per share minimum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class B common unit issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,268,279
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thresholds price per share maximum |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.36
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class B Common Units | Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
$ 0.52
|
|
|
|
|
$ 5.74
|
|
|
|
$ 5.74
|
5.74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.409
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
65,303
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
|
|
|
$ 279,812
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable warrant outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
65,303
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of stock units into warrants, shares issued |
|
|
|
|
|
|
|
65,303
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series 1b Preferred Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net of issuance costs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 40,405
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common units issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,268,279
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of preferred units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 6,500,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Estimated fair value of common stock issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,340,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Series 1b Preferred Units | Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred units, issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
$ 5.74
|
|
|
|
$ 5.74
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consideration of warrants exercised |
|
|
|
|
|
|
|
|
$ 18,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of warrant |
|
|
|
|
|
|
|
$ 65,303
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net issuance cost |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 19,868
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock units, fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
618,801
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Description of warrant |
|
|
|
|
|
|
|
|
|
|
up to an aggregate number of Series 1a Preferred Units not to exceed the product of 25% and the aggregate number of Series 1a Preferred Units then held by such Series 1a Preferred Member, which was 1,231,250 units at December 31, 2020. The exercise price for each Warrant Unit was $1.00, subject to adjustment for unit splits and combinations. The warrants had a 5-year term
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 4,381,199
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants, exercised during period |
|
|
|
|
|
|
|
|
18,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common and Pre-Funded Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price per share |
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.0001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common stock, shares sold |
|
|
|
|
|
|
|
|
|
|
|
|
898,585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase one share of common stock |
|
|
|
|
|
|
|
|
|
|
|
|
3,773,585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Warrants sold to purchase one share of common stock, Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.325
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding |
|
|
|
|
|
|
|
|
|
|
|
|
3,773,585
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercise price |
|
|
|
|
|
|
|
|
|
|
|
|
$ 1.325
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A Common Units |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common units issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
508,777
|
Consideration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10,430
|
Common Stock and Preferred Stock | Convertible Promissory Notes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Conversion of Stock, Shares Issued |
|
|
|
|
|
32,219
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Conversion, Converted Instrument, Principal Amount |
|
|
|
|
|
$ 175,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Debt Conversion, Converted Instrument, Accrued Interest |
|
|
|
|
|
$ 5,434
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|